Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01621334 · ClinicalTrials.gov registry record · Phase 1

The Men's Domestic Abuse Check-Up Engages Adult Men Concerned About Their Abusive Behavior and Alcohol or Drug Use

A Phase 1 study of Substance Abuse and Domestic Violence, sponsored by University of Washington.

Completed
Registry status
Phase 1
Development phase
140
Enrollment target
1
Study location

NCT01621334: Completed Phase 1 study of Substance Abuse and Domestic Violence, sponsored by University of Washington.

NCT01621334 is a Phase 1 study of Substance Abuse and Domestic Violence that has completed, run by University of Washington. The registered enrollment target is 140 participants, below the 5,257-participant average among 58 other Substance Abuse trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01621334, a Phase 1 study of Substance Abuse and Domestic Violence, has completed, sponsored by University of Washington.

COMPLETED
Registry status
Phase 1
Development phase
140 participants
Enrollment target
1
Study location

Study Summary

This research is a stage 1b developmental trial evaluating an intervention called "The Men's Domestic Abuse Check-Up" with adult men abusing their intimate partners and also struggling with alcohol or drug use.

Interventions

  • BEHAVIORAL Motivational Enhancement Therapy
  • BEHAVIORAL Educational information

Study Locations (1)

Washington

  • Innovative Programs Research Group, School of Social Work, University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2009-09
Est. Completion 2012-05
Phase Phase 1
University of Washington

1,048 total trials

What the finished NCT01621334 record still lists

NCT01621334 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 5,257-participant average among 58 other Substance Abuse trials with a reported enrollment target (97% lower).

The record links to 2 conditions, with Substance Abuse appearing as the primary indexed condition, and to 2 interventions - of which Motivational Enhancement Therapy is the first listed.

NCT01621334 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT01621334 about?

NCT01621334 is a clinical study titled "The Men's Domestic Abuse Check-Up Engages Adult Men Concerned About Their Abusive Behavior and Alcohol or Drug Use". This research is a stage 1b developmental trial evaluating an intervention called "The Men's Domestic Abuse Check-Up" with adult men abusing their intimate partners and also struggling with alcohol or drug use.

What is the current status of trial NCT01621334?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 140 participants. The study started on 2009-09. Estimated completion is 2012-05.

What conditions does trial NCT01621334 study?

This clinical trial studies the following conditions: Substance Abuse, Domestic Violence.

What interventions are being tested in trial NCT01621334?

The interventions under investigation include: Motivational Enhancement Therapy (BEHAVIORAL), Educational information (BEHAVIORAL).

Who is sponsoring clinical trial NCT01621334?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01621334 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Abuse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01621334's enrollment target sits among peer trials

140 31st of 58 higher than 27 of 58 other Substance Abuse trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Substance Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01419561 · 140 participants · Phase 2

    Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)

  • NCT01624805 · 140 participants · Phase 2

    Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome

  • NCT02369770 · 140 participants · NA

    Sensory-Motor Rehabilitation Post Stroke

  • NCT02455193 · 140 participants · NA

    Neuronal Effects of Exercise in Schizophrenia

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01621334, the US trial registry maintained by the National Library of Medicine. NCT01621334 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.